Currently out of the existing stock ratings of Catherine Novack, 1 are a BUY (50%), 1 are a HOLD (50%).

Catherine Novack

Work Performance Price Targets & Ratings Chart

Analyst Catherine Novack works at JONESTRADING

Catherine Novack’s has documented 3 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on KZR, Kezar Life Sciences at 05-Oct-2023.

Wall Street Analyst Catherine Novack

Analyst best performing recommendations are on KZR (KEZAR LIFE SCIENCES).
DARE Dare Bioscience KZR Kezar Life Sciences ALDX Aldeyra The

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

4

$3.46 (640.74%)

2 years 2 months 26 days ago

0/1 (0%)

$2.38 (146.91%)

Buy

9

$8.46 (1566.67%)

2 years 9 months 14 days ago

0/1 (0%)

$7.11 (376.19%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Catherine Novack?

On 2022

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?